A series of failed loan recast programmes continues to haunt banks.
Airbus recently bagged large orders from Indian airlines such as Indigo and Go Air.
Domestic and foreign companies pour in a slew of investments in Gujarat.
The change from wholesale to retail inflation as an anchor means that the weightage of diesel in inflation has decreased
RBI conducts interviews for first lateral hire for CGM post; deputy governors to head four distinct verticals.
May invest around $100 mn in setting up a 200-acre park
Industry insiders expect Chinese tourists coming to India to double in around two years.
Proposed investment dip 33% from Rs 1.42 lakh crore (Rs 1.42 trillion) in 2011 to Rs 94,259 crore (Rs 942.59 billion) in 2013
The move to make the appointment process more robust comes after last month's arrest of S K Jain, chairman and managing director of Syndicate Bank last month, over graft charges.
SBI's number of foreign offices increased from 186 in March 2013 to 190 in March 2014, in 36 countries.
Twenty-year-old Ripal Prajapati had to settle for mailing a 'rakhi' to her god-brother this time around.
In an interview with Business Standard, Arundhati Bhattacharya says she expects stalled projects coming back on track in two quarters.
The creation of the Amul brand and its famous mascot gave a rural revolution a durable competitive edge.
Deepak Narang, executive director of United Bank of India, speaks on Vijay Mallya's 'wilful defaulter' status.
Their net NPA as a proportion of net advances were 2.2 per cent, compared with 1.7 per during the same period a year earlier.
The Governor, who completes one year in RBI on Wednesday, has stabilised the rupee and is getting a fix on inflation.
SBI Caps readies plan, identifies 4 assets; bankers say there are enough bidders.
The finance ministry has ruled out the proposal for the appointment of a chief operating officer (COO) of the rank of deputy governor in the Reserve Bank of India (RBI), as the government feels no interim arrangements should be made for such high-profile appointments.
Sun Pharma to retain these in most markets; US could be the exception, where the Ranbaxy name has taken a hit.
Move comes after the country's monetary authority tightened credit norms